1. P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES. (23rd June 2022) Authors: Vassilakopoulos, T.; Ferhanoglu, B.; Horowitz, N. A.; Apostolidis, J.; Mellios, Z.; Kaynar, L.; Zektser, M.; Symeonidis, A.; Piperidou, A.; Kalpadaki, C.; Akay, O. M.; Atalar, S. C.; Sayyed, A.; Katodritou, E.; Leonidopoulou, T.; Papageorgiou, S.; Tadmor, T.; Gutwein, O.; Karakatsanis, S.; Ganzel... Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P578: GILTERITINIB FOR RELAPSED/REFRACTORY FLT3 MUTATED ACUTE MYELOID LEUKEMIA A REAL-WORLD, MULTI-CENTER, MATCHED ANALYSIS. (23rd June 2022) Authors: Shimony, S.; Canaani, J.; Kugler, E.; Nachmias, B.; Ram, R.; Frisch, A.; Ganzel, C.; Vainstein, V.; Moshe, Y.; Aumann, S.; Yeshurun, M.; Ofran, Y.; Raanani, P.; Wolach, O. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗